Extracorporeal immunomodulation in patients with hepatocellular carcinoma with lymphokine activated killer cells

Prog Clin Biol Res. 1990:337:459-67.

Authors

T Saibara¹, M Fujikawa, S Iwamura, Y Matsuura, E Ido, H Sakaeda, A Tomita, Y Matsunaga, T Maeda, S Onishi, et al.

Affiliation

¹ First Department of Internal Medicine, Kochi Medical School, Japan.

PMID: 2162063

No abstract available

Publication types

Clinical Trial

MeSH terms

Aged
Carcinoma, Hepatocellular / immunology
Carcinoma, Hepatocellular / therapy*
Clinical Trials as Topic
Cytotoxicity, Immunologic
Female
Humans
Immunization, Passive*
Interferon-gamma / biosynthesis
Interleukin-2 / therapeutic use
Killer Cells, Lymphokine-Activated / immunology*
Killer Cells, Natural / immunology
Liver Neoplasms / immunology
Liver Neoplasms / therapy*
Male
Middle Aged

Substances

Interleukin-2
Interferon-gamma